IAG is Attending the WCO-IOF-ESCEO Congress in Rome!
Rome, Italy – IAG (Imaging Analysis Group) is thrilled to announce its participation in the prestigious World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025), taking place at the Roma Convention Center – La Nuvola from April 10–13, 2025.
The WCO-IOF-ESCEO Congress is the leading global event for clinical research and advancements in bone, joint, and muscle health. It brings together healthcare professionals, researchers, and industry leaders to discuss cutting-edge developments in musculoskeletal diseases.
Where to Find Us:
The IAG team will be available throughout the congress to engage with medical directors, operational leaders, and industry experts. We invite you to explore how our innovative imaging solutions can transform your clinical trials by delivering precise and actionable data for musculoskeletal disease research.
Read our white paper: Download here
Watch DYNAMIKA Video: View here
E: contact@ia-grp.com
Why Meet IAG?
-
Expertise in Imaging Biomarkers: Learn how IAG’s advanced imaging analytics support drug development in osteoporosis, osteoarthritis, and sarcopenia.
-
Customized Solutions: Discuss tailored strategies to optimize imaging endpoints for your trials.
-
Collaborative Opportunities: Discover how partnering with IAG can streamline your trial operations and enhance regulatory submissions.
Join us at this exciting event as we work together to advance musculoskeletal disease management and improve patient outcomes.
To schedule a meeting with our team or learn more about our services, please contact us at contact@ia-grp.com
We look forward to connecting with you at WCO-IOF-ESCEO 2025!
About Image Analysis Group (IAG)
Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed. For nearly 20 years, the IAG team helped to reduce investment risk and to accelerate study outcomes in over 700 trials, empowering biotech and pharma sponsors to make data-driven decisions with confidence.